Filing Details

Accession Number:
0001415889-24-002936
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-07 16:38:06
Reporting Period:
2024-02-06
Accepted Time:
2024-02-07 16:38:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1999480 Alto Neuroscience Inc. ANRO Pharmaceutical Preparations (2834) 834210124
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
2008707 Adam Savitz C/O Alto Neuroscience, Inc.
369 South San Antonio Road
Los Altos CA 94022
Chief Medical Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-02-06 7,851 $0.00 7,851 No 4 C Indirect By Trust
Common Stock Acquisiton 2024-02-06 17,000 $16.00 24,851 No 4 P Indirect By Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect By Trust
No 4 P Indirect By Trust
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series B Preferred Stock Disposition 2024-02-06 16,666 $0.00 7,851 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
Footnotes
  1. Each share of Series B Preferred Stock was convertible at any time, at the holder's election, and automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering on a 2.1226069 for 1 basis and had no expiration date.
  2. The shares are directly held by Robert L. Friedman 2003 Long-Term Trust fbo Lisa Savitz (the "Friedman Trust"). The spouse of the Reporting Person is the beneficiary of the Friedman Trust, and the Reporting Person may be deemed to share beneficial ownership of the securities held by the Friedman Trust.